AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.100
0.00 (0.00%)
At close: Jul 25, 2025, 4:00 PM
1.120
+0.020 (1.82%)
After-hours: Jul 25, 2025, 6:47 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $33.19 million as of July 25, 2025. Its market cap has decreased by -56.36% in one year.
Market Cap
33.19M
Enterprise Value
-33.87M
1-Year Change
-56.36%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $33.19M, a decrease of -88.19%. That is a compound annual growth rate of -47.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 33.19M | -19.50% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.04B |
| Johnson & Johnson | 404.05B |
| AbbVie | 330.51B |
| Novo Nordisk | 295.77B |
| UnitedHealth Group | 258.65B |
| Novartis AG | 224.80B |
| Abbott Laboratories | 218.75B |
| AstraZeneca | 216.82B |